Research updates 65-year-old genetic discovery
Gene variants determine which humans and which chimpanzees can taste bitter substances. For humans, this taste sensitivity may influence nutritional choices and ultimately their health, as well as behaviors, such as smoking. For chimpanzees, it provides a way to live safely in their environments by avoiding toxic plants and other harmful compounds. Research conducted more 65 years ago by a...Solinus updates MailFoundry anti-spam hardware, switching to Linux
The MailFoundry 2100 is about three times as fast as the MailFoundry 1100, according to sales exec...Tech Digest: Merge eMed product updates; Renaissance Learning 3rd qtr results
, a Merge Healthcare company and a leading medical imaging software and services company, today announced the release of eFilm Workstation 2.1 and its plug-in Advanced Visualization and Clinical Application software modules. This latest release of the widely used deskt...Merge announces sofware updates, upcoming acquisition
Merge eFilm, the business name of Merge Technologies Incorporated, expects to close the deal with the San Francisco-based company in first-quarter 2005....Wingra Technologies updates data migration software
MADISON, Wis. The software can handle multiple users' mailboxes at a time withou...WHO Updates Outdated Pediatric Growth Charts
The World Health Organization (WHO) is in the process of updating the pediatric growth charts. The outdated charts will be replaced with the new one, which will present// the rates at which the babies are supposed to grow, in a more accurate form. The 20-year old charts are said to be based on growth patterns of babies fed formula-milk. The revision is based on growth data from breast...Drug Facts - Silver (A to Z Drug Facts with Auto-Updates)
Description:A to Z Drug Facts produced by Facts and Comparisons, provides detailed information on thousands of medications. It provides information on dosing, indications, contraindications, side effect, drug interactions, patient information and more. It is the ideal drug reference for physicians, students, residents, pharmacists, nurses, nurse practitioners, and physicians assistants....Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
NEWTON, Mass.--(BUSINESS WIRE)--Jul 9, 2007 - Pro-Pharmaceuticals,Inc. (Amex: PRW), a company "Advancing Drugs ThroughGlycoscience(R)", today updated the progress of its Phase IIclinical trial for first-line treatment of metastatic, unresectablecolorectal cancer patients who are unable to tolerate irinotecanand/or oxaliplatin, and its Phase II clinical trial for first-linetreatment of bilia...Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
GERMANTOWN, Md., June 13, 2007 /PRNewswire-FirstCall/ -- AvalonPharmaceuticals, Inc. , today announced that it is will provide anupdate on the Phase I clinical trial of AVN944 in hematologicmalignancies on Tuesday, June 19, 2007, after the close of the U.S.financial markets. The Company will also host a conference call onWednesday, June 20, 2007 at 8 a.m. Eastern Time. Interestedinvestor...NCCN Updates Esophageal and Gastric Cancer Guidelines
JENKINTOWN, Pa.--(BUSINESS WIRE)--May 22, 2007 - The NationalComprehensive Cancer Network (NCCN) announces updates to two NCCNClinical Practice Guidelines in Oncology(TM) -- Esophageal Cancerand Gastric Cancer. The NCCN Guidelines are updated continuously bypanels of world-renowned experts and are widely recognized andapplied as the standard of care in oncology in the United States inboth t...